Clinical Trial Update: Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update exploring bevacizumab beyond progression in platinum-sensitive recurrent ovarian cancer is reported, though status details are not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: National Cancer Institute, Naples | Conditions: Recurrent Ovarian Cancer | Phase 3 | Status: UNKNOWN